Clinical Trials Logo

Efficacy and Safety clinical trials

View clinical trials related to Efficacy and Safety.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05481775 Withdrawn - Efficacy and Safety Clinical Trials

Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Start date: April 1, 2022
Phase: Phase 2
Study type: Interventional

This is a prospective, randomized, controlled phase II clinical study for evaluating anlotinib combined with concurrent chemoradiotherapy followed by consolidation immunotherapy versus concurrent chemoradiotherapy followed by consolidation immunotherapy in locally advanced, unresectable NSCLC.